Phase I study of dolastatin-10 in acute leukemias, myelodysplastic syndromes and chronic myeloid leukemia in blast phase
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dolastatin-10 (Primary)
- Indications Chronic myeloid leukaemia; Leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 25 Oct 2018 Biomarkers information updated
- 29 Sep 2005 New trial record.